Clindamycin Phosphate is the water-soluble phosphate ester prodrug of clindamycin that inhibits bacterial 50S ribosomal protein synthesis, used systemically for anaerobic and Gram-positive infections and topically for acne and bacterial vaginosis. Simson Pharma's Clindamycin Phosphate reference standard and impurities support compendial testing across these varied parenteral and topical formulations.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Clindamycin Phosphate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.